1. Home
  2. PHAT vs TH Comparison

PHAT vs TH Comparison

Compare PHAT & TH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAT
  • TH
  • Stock Information
  • Founded
  • PHAT 2018
  • TH 1978
  • Country
  • PHAT United States
  • TH United States
  • Employees
  • PHAT N/A
  • TH N/A
  • Industry
  • PHAT Biotechnology: Pharmaceutical Preparations
  • TH Hotels/Resorts
  • Sector
  • PHAT Health Care
  • TH Consumer Discretionary
  • Exchange
  • PHAT Nasdaq
  • TH Nasdaq
  • Market Cap
  • PHAT 727.5M
  • TH 692.6M
  • IPO Year
  • PHAT 2019
  • TH N/A
  • Fundamental
  • Price
  • PHAT $9.80
  • TH $7.16
  • Analyst Decision
  • PHAT Strong Buy
  • TH Hold
  • Analyst Count
  • PHAT 5
  • TH 3
  • Target Price
  • PHAT $16.40
  • TH $11.25
  • AVG Volume (30 Days)
  • PHAT 4.9M
  • TH 370.8K
  • Earning Date
  • PHAT 08-07-2025
  • TH 08-06-2025
  • Dividend Yield
  • PHAT N/A
  • TH N/A
  • EPS Growth
  • PHAT N/A
  • TH N/A
  • EPS
  • PHAT N/A
  • TH 0.43
  • Revenue
  • PHAT $81,859,000.00
  • TH $349,497,000.00
  • Revenue This Year
  • PHAT $195.45
  • TH N/A
  • Revenue Next Year
  • PHAT $106.76
  • TH $9.98
  • P/E Ratio
  • PHAT N/A
  • TH $16.64
  • Revenue Growth
  • PHAT 3055.70
  • TH N/A
  • 52 Week Low
  • PHAT $2.21
  • TH $4.00
  • 52 Week High
  • PHAT $19.71
  • TH $11.10
  • Technical
  • Relative Strength Index (RSI)
  • PHAT 66.25
  • TH 53.13
  • Support Level
  • PHAT $8.86
  • TH $7.07
  • Resistance Level
  • PHAT $11.21
  • TH $7.41
  • Average True Range (ATR)
  • PHAT 1.59
  • TH 0.21
  • MACD
  • PHAT -0.06
  • TH 0.01
  • Stochastic Oscillator
  • PHAT 63.60
  • TH 68.13

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. Its operating segment includes HFS-South and HFS-Midwest; Government; TCPL Keystone and others. It generates a majority of its revenue from the Government segment which consists of specialty rental and vertically integrated hospitality services revenue from customers with Government contracts located in Texas.

Share on Social Networks: